MedChem
This article was originally published in The Gray Sheet
Executive Summary
President and Chief Operating Officer Edward Covell is appointed president of the company's Gesco International division, assuming responsibility for the intravenous access business. Covell's old post is not expected to be filled and he will continue to report to Chief Executive Officer Jonathan Donaldson. MedChem Senior VP-Sales & Marketing Bradford Gay is appointed president of MedChem's surgical division, overseeing the hemostasis business. The Woburn, Massachusetts firm says the restructuring will "sharpen its focus on its two strategic business units: the hemostasis business (the Avitene family of products) and the intravenous access business"